MS4A4A modifies the risk of Alzheimer disease by regulating lipid metabolism and immune response in a unique microglia state.
Journal
medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986
Informations de publication
Date de publication:
08 Feb 2023
08 Feb 2023
Historique:
pubmed:
18
2
2023
medline:
18
2
2023
entrez:
17
2
2023
Statut:
epublish
Résumé
Genome-wide association studies (GWAS) have identified many modifiers of Alzheimer disease (AD) risk enriched in microglia. Two of these modifiers are common variants in the
Identifiants
pubmed: 36798226
doi: 10.1101/2023.02.06.23285545
pmc: PMC9934804
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NIA NIH HHS
ID : R56 AG067764
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG062734
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG058501
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS127211
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS118146
Pays : United States
Organisme : NIA NIH HHS
ID : U19 AG032438
Pays : United States